Back to Products
Syrup
MOKSOKOR-CV 228
Amoxycillin (200 mg), Clavulanic Acid (28.5 mg)
Ramitra Biotech presents MOKSOKOR-CV 228, containing Amoxycillin (200 mg), Clavulanic Acid (28.5 mg), a high-trust Syrup in 1 x 1 [30ml] packing validated for quality assurance and certified under WHO-GMP protocols for healthcare providers across India.
📋 Specifications
| Product Name | MOKSOKOR-CV 228 |
|---|---|
| Composition | Amoxycillin (200 mg), Clavulanic Acid (28.5 mg) |
| Category | Syrup |
| Packaging | 1 x 1 [30ml] |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
MOKSOKOR-CV 228.5 Syrup, a potent antibiotic formulation, is presented in a practical 30ml unit pack.
Formulated with Amoxycillin 200 mg and Clavulanic Acid 28.5 mg per dose, providing a powerful synergistic antibacterial action.
Clavulanic Acid effectively inhibits beta-lactamase enzymes, thereby protecting Amoxycillin and extending its efficacy against resistant bacterial strains.
Designed as an oral syrup, this formulation ensures ease of administration, particularly beneficial for pediatric patients or individuals with swallowing difficulties.
MOKSOKOR-CV 228.5 is indicated for the treatment of a broad range of bacterial infections, enhancing treatment outcomes where resistance is a concern.
Manufactured by Ramitra Biotech, ensuring high quality, purity, and consistent therapeutic efficacy for optimal patient care.
Quantity
